SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $862,623,135 |
| Positions | 5 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| WAYSTAR HLDG CORP | WAY | COM | $510,774,842 | 24,879,437 |
| PHARVARIS N V | PHVS | COM | $118,422,979 | 3,424,609 |
| OCULIS HOLDING AG | OCS | ORDINARY SHARES | $96,400,578 | 6,950,294 |
| EVOMMUNE INC | EVMN | COM SHS | $70,281,680 | 5,288,313 |
| AGOMAB THERAPEUTICS NV | AGMB | SPONSORED ADS | $66,743,056 | 5,141,992 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.